135 related articles for article (PubMed ID: 12434715)
41. Foscavir receives new indication.
AIDS Alert; 1997 Jun; 12(6):71. PubMed ID: 11364364
[TBL] [Abstract][Full Text] [Related]
42. Fomivirsen.
Perry CM; Balfour JA
Drugs; 1999 Mar; 57(3):375-80; discussion 381. PubMed ID: 10193689
[TBL] [Abstract][Full Text] [Related]
43. From the Food and Drug Administration.
Schwetz BA
JAMA; 2001 Jun; 285(21):2705. PubMed ID: 11386912
[No Abstract] [Full Text] [Related]
44. Advances in antisense efficacy and delivery.
Agrawal S; Akhtar S
Trends Biotechnol; 1995 Jun; 13(6):197-9. PubMed ID: 7598842
[No Abstract] [Full Text] [Related]
45. Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A.
Mizuta T; Fujiwara M; Hatta T; Abe T; Miyano-Kurosaki N; Shigeta S; Yokota T; Takaku H
Nat Biotechnol; 1999 Jun; 17(6):583-7. PubMed ID: 10385324
[TBL] [Abstract][Full Text] [Related]
46. From the Food and Drug Administration.
Nightingale SL
JAMA; 1995 Oct; 274(14):1109. PubMed ID: 7563473
[No Abstract] [Full Text] [Related]
47. Prospects for antisense therapy are looking brighter.
Bonn D
Lancet; 1996 Mar; 347(9004):820. PubMed ID: 8622343
[No Abstract] [Full Text] [Related]
48. Spinal muscular atrophy approval boosts antisense drugs.
Dolgin E
Nat Biotechnol; 2017 Feb; 35(2):99-100. PubMed ID: 28178250
[No Abstract] [Full Text] [Related]
49. Antisense has growing pains.
Gura T
Science; 1995 Oct; 270(5236):575-7. PubMed ID: 7570012
[No Abstract] [Full Text] [Related]
50. Crohn's trial shows the pros of antisense.
Robertson D
Nat Biotechnol; 1997 Mar; 15(3):209. PubMed ID: 9062911
[No Abstract] [Full Text] [Related]
51. Oral ganciclovir.
Schouten JT
STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
[TBL] [Abstract][Full Text] [Related]
52. Antisense drug discovery and development.
Yamamoto T; Nakatani M; Narukawa K; Obika S
Future Med Chem; 2011 Mar; 3(3):339-65. PubMed ID: 21446846
[TBL] [Abstract][Full Text] [Related]
53. Antisense therapy in oncology: new hope for an old idea?
Tamm I; Dörken B; Hartmann G
Lancet; 2001 Aug; 358(9280):489-97. PubMed ID: 11513935
[TBL] [Abstract][Full Text] [Related]
54. Drug treatment for Crohn's disease.
Yacyshyn BR
Lancet; 1998 Aug; 352(9129):743. PubMed ID: 9729027
[No Abstract] [Full Text] [Related]
55. Progress in antisense therapeutics.
Crooke ST
Hematol Pathol; 1995; 9(2):59-72. PubMed ID: 7559256
[TBL] [Abstract][Full Text] [Related]
56. Antisense oligonucleotides in lung cancer.
Pujol JL; Jacot W
Suppl Tumori; 2002; 1(4):S50-1. PubMed ID: 12415820
[No Abstract] [Full Text] [Related]
57. Clinical trials referral resource. Current clinical trials of G3139.
Tock B; Zwiebel JA; Schoenfeldt M
Oncology (Williston Park); 2003 Sep; 17(9):1244-6, 1251-3, 1258. PubMed ID: 14569852
[No Abstract] [Full Text] [Related]
58. Advances in treatment for cytomegalovirus retinitis.
Bowers M
BETA; 1995 Sep; ():13-5. PubMed ID: 11362885
[TBL] [Abstract][Full Text] [Related]
59. Gene therapy for HIV.
Lever AM
Sex Transm Infect; 2001 Apr; 77(2):93-6. PubMed ID: 11287684
[No Abstract] [Full Text] [Related]
60. New drug recommended for treatment of CMV retinitis.
Bray JM
STEP Perspect; 1996; 8(1):8. PubMed ID: 11363593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
